Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2404

Feb 16, 2017

Company Claims Brain Transplants Could Bring Back the Dead by 2045

Posted by in categories: biotech/medical, cyborgs, life extension, military, nanotechnology, neuroscience, Ray Kurzweil, robotics/AI, singularity

Not too shock by this given other transplant patient’s stories of memories, etc.


1 brains
There are a lot of outrageous claims being made within the halls of neuroscience and artificial intelligence. Whether exaggerations, wishful thinking, the dreams of the egocentric and megalomaniacal to be immortal, or just drumming up funding for a never-ending round of “scientific investigation,” the year 2045 seems to always be cited as a target date.

Continue reading “Company Claims Brain Transplants Could Bring Back the Dead by 2045” »

Feb 16, 2017

Aubrey de Grey — A Post-Aging Planet

Posted by in categories: biotech/medical, life extension

https://www.youtube.com/watch?v=hJzrXZb1G3E

A great Q&A, especially with the deathists that crop up.


Website ► http://sens.org
YouTube ► https://www.youtube.com/user/SENSFVideo
Facebook ► https://www.facebook.com/sensf
Twitter ► https://twitter.com/senstweet

Continue reading “Aubrey de Grey — A Post-Aging Planet” »

Feb 16, 2017

Woolly mammoths may be brought back from extinction in just TWO YEARS

Posted by in categories: bioengineering, biotech/medical

Scientists from Harvard University plan to create a mammoth hybrid. They will splice mammoth DNA preserved in Siberian ice with Asian elephant DNA and grow the hybrid in an artificial womb.

Read more

Feb 16, 2017

The small molecule AUTEN-99 (autophagy enhancer-99) prevents the progression of neurodegenerative symptoms

Posted by in categories: biotech/medical, life extension, neuroscience

New research on Parkinson and holds additional insights in cell & neuro technology.


Autophagy functions as a main route for the degradation of superfluous and damaged constituents of the cytoplasm. Defects in autophagy are implicated in the development of various age-dependent degenerative disorders such as cancer, neurodegeneration and tissue atrophy, and in accelerated aging. To promote basal levels of the process in pathological settings, we previously screened a small molecule library for novel autophagy-enhancing factors that inhibit the myotubularin-related phosphatase MTMR14/Jumpy, a negative regulator of autophagic membrane formation. Here we identify AUTEN-99 (autophagy enhancer-99), which activates autophagy in cell cultures and animal models. AUTEN-99 appears to effectively penetrate through the blood-brain barrier, and impedes the progression of neurodegenerative symptoms in Drosophila models of Parkinson’s and Huntington’s diseases. Furthermore, the molecule increases the survival of isolated neurons under normal and oxidative stress-induced conditions. Thus, AUTEN-99 serves as a potent neuroprotective drug candidate for preventing and treating diverse neurodegenerative pathologies, and may promote healthy aging.

Read more

Feb 16, 2017

Smart threads for in vitro and in vivo diagnostics

Posted by in categories: biotech/medical, health

Nice.


A suite of flexible and biocompatible threads, embedded with sensors and electronics, can be sutured/woven into tissue for in situ measurements of physical and chemical biomarkers.

Continue reading “Smart threads for in vitro and in vivo diagnostics” »

Feb 16, 2017

Brain implants might soon restore vision to the blind, improve digestion, relieve PTSD symptoms

Posted by in categories: biotech/medical, robotics/AI

[Brain implant experiments] like those that let a paralyzed person swig coffee using a robotic arm, or that let blind people “see” spots of light, have proven the huge potential of computers that interface with the brain. But the implanted electrodes used in such trials eventually become useless, as scar tissue forms that degrades their electrical connection to brain cells.

[However,] tests will begin in monkeys of a new implant for piping data into the brain that is designed to avoid that problem. [Led by Harvard researchers,] the project is intended to lead to devices that can restore vision to blind people long-term…[The device will] go beneath the skull but can rest on the surface of an animal’s brain, instead of penetrating inside the organ.

Read more

Feb 16, 2017

Five ways nanoscience is making science fiction into fact

Posted by in categories: biotech/medical, nanotechnology

Russian author Boris Zhitkov wrote the 1931 short story Microhands, in which the narrator creates miniature hands to carry out intricate surgeries. And while that was nearly 100 years ago, the tale illustrates the real fundamentals of the nanoscience researchers are working on today.

Nanoscience is the study of molecules that are one billionth of a metre in size. To put this into perspective, a human hair is between 50,000 and 100,000 nanometres thick. At this tiny size, materials possess properties that lie somewhere between a lump of metal and that of a single atom. This unique environment means they can become very reactive and be used as catalysts.

Continue reading “Five ways nanoscience is making science fiction into fact” »

Feb 16, 2017

The strange link between the human mind and quantum physics

Posted by in categories: biotech/medical, neuroscience, quantum physics

The problems that I have seen when limiting the topic of quantum mechanics to the human mind topic is that the relationship around Quantum Mechanics to biology is missed completely. For example, it has only be in the recent few years that scientists began to understand Quantum Mechanics Action of ELF electromagnetic fields and its relationship to human cells. And, this find has open valuable research in how cells can (through electromagnetic fields can spin a low temperatures) mimic telepathy communicating between the human cells.


Nobody understands what consciousness is or how it works. Nobody understands quantum mechanics either. Could that be more than coincidence?

Read more

Feb 15, 2017

Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight

Posted by in categories: biotech/medical, food, genetics

The Broad Institute in Cambridge, Mass., will retain potentially lucrative rights to a powerful gene-editing technique that could lead to major advances in medicine and agriculture, the federal Patent and Trademark Office ruled on Wednesday.

The decision, in a bitterly fought dispute closely watched by scientists and the biotechnology industry, was a blow to the University of California, often said to be the birthplace of the technique, which is known as Crispr-Cas9.

An appeals board of the patent office ruled that the gene-editing inventions claimed by the two institutions were separate and do not overlap.

Read more

Feb 15, 2017

Combination immunotherapies kill brain cancer in mice – study

Posted by in categories: biotech/medical, neuroscience

Scientists have discovered a groundbreaking immunotherapy combination that kills brain cancer, promotes long-term immunity and is highly effective against breast cancer and myeloma.

Researchers at the Children’s Hospital of Eastern Ontario (CHEO) in Ottawa had the promising findings published Wednesday in the journal ‘Nature Communications’.

The study outlines how the team developed a unique combination of drugs known as SMAC Mimetics and immune checkpoint inhibitors (ICIs) that produce high kill rates for cancer tumor cells in mice.

Read more